Getting an accurate acute myeloid leukemia (AML) diagnosis, and identifying its subtype is extremely important in determining the treatment for your AML. This is because different subtypes of AML respond to different drugs and treatment therapies.
Also, depending on your prognosis, different therapies may be used and recommended.
If you were diagnosed at another health care center, and are coming to the Abramson Cancer Center for treatment or a second opinion, repeat diagnostic tests may be necessary. This is because here, we have access to the latest diagnostic imaging tools, tests and procedures to navigate your personalized treatment plan.